NKTR Competitors & Alternatives
Compare Nektar Therapeutics with similar stocks in the same industry
Biotechnology
NKTR
Main Stock$70.59
Tradestie Score
63
Market Cap
$1.12B
Revenue Growth
0.0%
Analyst Upside
+117.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$25.91
|
$2.44B | - | 48 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$61.32
|
$2.42B | - | 46 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$154.79
|
$2.41B | - | 51 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.40
|
$2.40B | - | 56 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.94
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.11
|
$2.35B | - | 47 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.15
|
$2.34B | - | 47 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.31
|
$2.33B | - | 60 | Compare |
More NKTR Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry